Target Identification/ Validation News for July 2010

Target Identification/ Validation News Archive

Pharma ‘HTS’ the mark with screening Pharma ‘HTS’ the mark with screening

In May, it was announced that new research into stem cell reprogramming would reduce the need for animal testing; now, we are really beginning to see the benefits of this groundbreaking science.

‘Skills swap’ for patient benefit ‘Skills swap’ for patient benefit

Cancer Research Technology and Medical Research Council Technology plan to ‘swap’ medical discoveries to accelerate the translation of early scientific research into patient benefit.

New access to remnant patient sample library New access to remnant patient sample library

SeraCare is now offering access to an extensive and constantly replenished library of remnant patient samples consisting of serum, plasma, urine, cerbrospinal fluid and amniotic fluid for pre-clinical research studies.